CLINICAL_TRIALS
trial_result
· 2012-09-11
Clinical Trial Update: PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma [Phase 2]
Summary
Phase 2 trial evaluating PS-341 (bortezomib) alone and with EPOCH chemotherapy for Non-Hodgkin lymphoma; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: B-Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2012-09-11